Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With so many shares to choose from on the ASX, it can be difficult to decide which ones to buy. The good news is that brokers across the country are doing a lot of the hard work for you.

Three top ASX shares that leading brokers have named as buys this week are listed below. Here's why they are bullish on them:

Investor sitting in front of multiple screens watching share prices

Image source: Getty Images

Collins Foods Ltd (ASX: CKF)

According to a note out of Citi, its analysts have initiated coverage on this quick service restaurant operator's shares with a buy rating and $12.80 price target. The broker believes that Collins Foods' operating earnings can nearly double between now and FY 2031. This is expected to be driven by the rollout of KFC in the Netherlands and Australia. The Collins Foods share price is trading at $10.34 on Monday afternoon.

Dicker Data Ltd (ASX: DDR)

A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $10 price target on this computer hardware and software developer's shares. This follows the release of the company's half-year update last week. While Dicker Data's revenue was softer than expected, its margins were much stronger than the broker anticipated. In light of this, Morgan Stanley feels the company is on track to achieve its earnings estimates in FY 2023. The Dicker Data share price is fetching $8.11 today.

ResMed Inc. (ASX: RMD)

Another note out of Citi reveals that its analysts have retained their buy rating on this sleep treatment company's shares with a trimmed price target of $39. While the broker was disappointed with ResMed's margin recovery, it was pleased with its strong top-line growth. And with management expecting its margins to improve in FY 2024, Citi remains positive on ResMed and retains its buy rating. The ResMed share price is trading at $29.30 today.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has positions in Collins Foods. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Collins Foods, Dicker Data, and ResMed. The Motley Fool Australia has positions in and has recommended Dicker Data and ResMed. The Motley Fool Australia has recommended Collins Foods. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Man smiling ahead while working on his MacBook.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Time to sell written on a clock.
Broker Notes

Sell alert! Why this expert is calling time on Westpac and CBA shares

A leading expert forecasts growing headwinds for Westpac and CBA shares.

Read more »

Man looking at digital holograms of graphs, charts, and data.
Broker Notes

Expert names 2 ASX tech shares to buy today

A top analyst says these two ASX tech stocks are well-positioned to outperform.

Read more »

A female ASX investor looks through a magnifying glass that enlarges her eye and holds her hand to her face with her mouth open as if looking at something of great interest or surprise.
Broker Notes

4 ASX All Ords shares with 40% to 90% upside post-results: experts

These shares have major upside potential, according to the experts.

Read more »

Woman looking at a laptop and thinking.
Broker Notes

4 ASX shares scoring upgrades in the final week of earnings season

Brokers have increased their ratings on Sigma Healthcare, Adairs, Netwealth, and other shares.

Read more »

Broker written in white with a man drawing a yellow underline.
Broker Notes

Buy, hold, sell: Netwealth, Sigma Healthcare, and Wesfarmers shares

The team at Morgans has given its verdict on these shares.

Read more »

Smiling kid flexing his muscles.
Broker Notes

3 ASX 200 shares to buy post-results: broker

Morgans has reviewed these companies' FY26 reports and given them a buy rating.

Read more »

Small kid giving a thumbs up.
Broker Notes

9 ASX 200 shares with strengthened buy ratings this week

Brokers are positive on Paladin Energy, Coles, WiseTech, Centuria Capital, and other shares.

Read more »